EMEA-000249-PIP01-08 - paediatric investigation plan

Influenza Virus Type A, H3N2Influenza Virus Type A, H1N1Influenza Virus Type B

Key facts

• Active substance:
  Influenza Virus Type A, H3N2Influenza Virus Type A, H1N1Influenza Virus Type B
• Therapeutic area:
  Vaccines
• Decision number:
  P/101/2008
• PIP number:
  EMEA-000249-PIP01-08
• Pharmaceutical form(s):
  Nasal spray suspension
• Condition(s) / indication(s):
  Influenza
• Route(s) of administration:
  Intranasal use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  03/11/2008
• Compliance check done:
  No

Decision

P/101/2008: European Medicines Agency decision of 3 November 2008 on the application for product specific waiver for influenza virus type A, H3N2, influenza virus type A, H1N1, influenza virus type B (EMEA-000249-PIP01-0...

Adopted Reference Number: EMEA/572430/2008